Literature DB >> 25692703

The interleukin-33-p38 kinase axis confers memory T helper 2 cell pathogenicity in the airway.

Yusuke Endo1, Kiyoshi Hirahara2, Tomohisa Iinuma3, Kenta Shinoda1, Damon J Tumes1, Hikari K Asou1, Nao Matsugae1, Kazushige Obata-Ninomiya1, Heizaburo Yamamoto4, Shinichiro Motohashi5, Keisuke Oboki6, Susumu Nakae7, Hirohisa Saito6, Yoshitaka Okamoto3, Toshinori Nakayama8.   

Abstract

Memory CD4(+) T helper (Th) cells provide long-term protection against pathogens and are essential for the development of vaccines; however, some antigen-specific memory Th cells also drive immune-related pathology, including asthma. The mechanisms regulating the pathogenicity of memory Th cells remain poorly understood. We found that interleukin-33 (IL-33)-ST2 signals selectively licensed memory Th2 cells to induce allergic airway inflammation via production of IL-5 and that the p38 MAP kinase pathway was a central downstream target of IL-33-ST2 in memory Th2 cells. In addition, we found that IL-33 induced upregulation of IL-5 by memory CD4(+) T cells isolated from nasal polyps of patients with eosinophilic chronic rhinosinusitis. Thus, IL-33-ST2-p38 signaling appears to directly instruct pathogenic memory Th2 cells to produce IL-5 and induce eosinophilic inflammation.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25692703     DOI: 10.1016/j.immuni.2015.01.016

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  74 in total

Review 1.  CD4+ T-cell subsets in inflammatory diseases: beyond the Th1/Th2 paradigm.

Authors:  Kiyoshi Hirahara; Toshinori Nakayama
Journal:  Int Immunol       Date:  2016-02-12       Impact factor: 4.823

Review 2.  The immunopathology of lung fibrosis: amphiregulin-producing pathogenic memory T helper-2 cells control the airway fibrotic responses by inducing eosinophils to secrete osteopontin.

Authors:  Kiyoshi Hirahara; Ami Aoki; Yuki Morimoto; Masahiro Kiuchi; Mikiko Okano; Toshinori Nakayama
Journal:  Semin Immunopathol       Date:  2019-04-09       Impact factor: 9.623

3.  IL-33 dysregulates regulatory T cells and impairs established immunologic tolerance in the lungs.

Authors:  Chien-Chang Chen; Takao Kobayashi; Koji Iijima; Fan-Chi Hsu; Hirohito Kita
Journal:  J Allergy Clin Immunol       Date:  2017-02-11       Impact factor: 10.793

4.  Pathogenicity of acquired immunity in human diseases.

Authors:  Kiyoshi Hirahara
Journal:  Semin Immunopathol       Date:  2019-05-07       Impact factor: 9.623

Review 5.  Pathogenic CD4+ T cells in patients with asthma.

Authors:  Lyndsey M Muehling; Monica G Lawrence; Judith A Woodfolk
Journal:  J Allergy Clin Immunol       Date:  2017-04-22       Impact factor: 10.793

6.  Experimental asthma persists in IL-33 receptor knockout mice because of the emergence of thymic stromal lymphopoietin-driven IL-9+ and IL-13+ type 2 innate lymphoid cell subpopulations.

Authors:  Mukesh Verma; Sucai Liu; Lidia Michalec; Anand Sripada; Magdalena M Gorska; Rafeul Alam
Journal:  J Allergy Clin Immunol       Date:  2017-11-10       Impact factor: 10.793

Review 7.  A worm of one's own: how helminths modulate host adipose tissue function and metabolism.

Authors:  Bruno Guigas; Ari B Molofsky
Journal:  Trends Parasitol       Date:  2015-05-16

8.  CXCR6+ST2+ memory T helper 2 cells induced the expression of major basic protein in eosinophils to reduce the fecundity of helminth.

Authors:  Kazushige Obata-Ninomiya; Kenji Ishiwata; Hisanobu Nakano; Yusuke Endo; Tomomi Ichikawa; Atsushi Onodera; Kiyoshi Hirahara; Yoshitaka Okamoto; Hirotaka Kanuka; Toshinori Nakayama
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-01       Impact factor: 11.205

9.  Exophilin-5 regulates allergic airway inflammation by controlling IL-33-mediated Th2 responses.

Authors:  Katsuhide Okunishi; Hao Wang; Maho Suzukawa; Ray Ishizaki; Eri Kobayashi; Miho Kihara; Takaya Abe; Jun-Ichi Miyazaki; Masafumi Horie; Akira Saito; Hirohisa Saito; Susumu Nakae; Tetsuro Izumi
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

Review 10.  Type 2 immunity in tissue repair and fibrosis.

Authors:  Richard L Gieseck; Mark S Wilson; Thomas A Wynn
Journal:  Nat Rev Immunol       Date:  2017-08-30       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.